APP
GWPH

Avantax Planning Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Avantax Planning Partners’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-126
Closed -$22K – 1352
2018
Q3 		$22K Buy
+126
New +$18.2K ﹤0.01% 680
2018
Q2 		– Sell
-126
Closed -$14K – 1687
2018
Q1 		$14K Buy
+126
New +$15.8K ﹤0.01% 923

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avantax Planning Partners's GWPH Position: Q4 2018 in Review

Avantax Planning Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 126 shares — an estimated $22K sold.

Avantax Planning Partners first reported a position in GWPH in Q1 2018 and held it in 2 quarters. The position peaked at $22K in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • Avantax Planning Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Avantax Planning Partners sold 126 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $22K.
  • Avantax Planning Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and held it in 2 quarters.
  • Avantax Planning Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $22K in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.